Circadian owns Vegenics

By Dylan Bushell-Embling
Thursday, 14 August, 2008

Circadian Technologies [ASX: CIR] is now the sole owner of Vegenics, having completed the acquisition of the company today.

Circadian announced the planned acquisition on July 15. Prior to that point, the company held a 66 per cent stake in Vegenics.

Among the intellectual property Circadian has assumed control of are the proteins VEGF-C and VEGF-D, which if blocked may inhibit rumour growth and prevent the spread of new cancer cells.

Circadian has also acquired Vegenics' product pipeline, including drug candidates based on the VEGF-C and VEGF-D protein IPs.

Content from other channels on our network

Daniel Wyner appointed Lumary CEO

Home care safeguards when disasters hit

"Historic legislation" allows authorised nurses to prescribe PBS medicines

You see what others miss

Tapping into the labour mobility market to fill ongoing workforce gaps

Demand increases for skilled sustainability professionals

Pilot program reduces food waste in SEQ

Yarra Valley Water to report net zero operational emissions

Recycling workers' lives at risk from hazardous waste

Biochar used for solar water purification

Energy crisis will have long‍-‍term effects: Australian Industry Group

Myriota launches hybrid 5G satellite and cellular IoT network

Funding program for smaller businesses to access additive manufacturing

Collaboration provides NZ's largest smart water meter upgrade

ARENA backs Sicona battery technology to boost EV performance

Circadian owns Vegenics

Scientists search for cystitis pain 'off switch'

Australia's first cases of H5 avian influenza confirmed

AusBiotech partners with Tenmile

Content from other channels on our network